| 國家衛生研究院 |
2018-02-11 |
Comparative effect of antipsychotics on risk of self-harm among patients with schizophrenia
|
Ma, CH;Chang, SS;Tsai, HJ;Gau, SS;Chen, IM;Liao, SC;Chien, YL;Hsieh, MH;Wu, CS |
| 臺大學術典藏 |
2018-09-10T18:06:05Z |
Comparative effect of antipsychotics on risk of self-harm among patients with schizophrenia.
|
C-H Ma, S-S Chang, H-J Tsai, S S-F Gau, I-M Chen, S-C Liao, Y-L Chien, M H Hsieh, C-S Wu; SUSAN SHUR-FEN GAU; SHIH-CHENG LIAO; CHI-SHIN WU |
| 國立成功大學 |
2020-04-8 |
Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan
|
Yang;Szu-Chun;Lai;Wu-Wei;Hsu;Jason, C.;Su;Wu-Chou;Wang;Jung-Der |
| 國立成功大學 |
2020-04 |
Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan
|
楊思雋; Yang, Szu-Chun; Lai, Wu-Wei;Hsu, Jason C.;Su, Wu-Chou;Wang, Jung-Der |
| 國立成功大學 |
2020 |
Comparative effectiveness and costeffectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan
|
Yang, S.-C.;Lai, W.-W.;Hsu, J.C.;Su, W.-C.;Wang, J.-D. |
| 臺大學術典藏 |
2020-02-25T09:10:23Z |
Comparative effectiveness and safety of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome or percutaneous coronary intervention
|
Wang, Y.-H.;Kao, H.-L.;Wang, C.-C.;Lin, S.-Y.;Fang-Ju Lin; Wang, Y.-H.; Kao, H.-L.; Wang, C.-C.; Lin, S.-Y.; FANG-JU LIN |
| 臺大學術典藏 |
2019 |
Comparative effectiveness and safety of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome or percutaneous coronary intervention
|
Wang Y.-H.; Kao H.-L.; Wang C.-C.; Lin S.-Y.; FANG-JU LIN |
| 臺大學術典藏 |
2020-12-25T08:38:32Z |
Comparative effectiveness and safety of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome or percutaneous coronary intervention
|
HSIEN-LI KAO; Wang C.-C.; Lin S.-Y.; Lin F.-J.; Wang Y.-H. |
| 臺大學術典藏 |
2019 |
Comparative effectiveness and safety of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome or percutaneous coronary intervention
|
Lin F.-J.; Lin S.-Y.; Wang C.-C.; HSIEN-LI KAO; Wang Y.-H. |
| 臺大學術典藏 |
2020-12-17T02:19:46Z |
Comparative effectiveness and safety of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome or percutaneous coronary intervention
|
Wang Y.-H.; Kao H.-L.; Wang C.-C.; Lin S.-Y.; FANG-JU LIN |
| 臺大學術典藏 |
2021-07-05T01:12:16Z |
Comparative effectiveness and safety of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome or percutaneous coronary intervention
|
Wang Y.-H.;Kao H.-L.;Chi-Chuan Wang;Lin S.-Y.;Lin F.-J.; Wang Y.-H.; Kao H.-L.; CHI-CHUAN WANG; Lin S.-Y.; Lin F.-J. |
| 臺大學術典藏 |
2021-07-08T08:19:42Z |
Comparative effectiveness and safety of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome or percutaneous coronary intervention
|
Wang Y.-H.;Kao H.-L.;Wang C.-C.;Shin Yi Lin;Lin F.-J.; Wang Y.-H.; Kao H.-L.; Wang C.-C.; SHIN YI LIN; Lin F.-J. |
| 臺大學術典藏 |
2020-12-17T02:40:29Z |
Comparative effectiveness and safety of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome or percutaneous coronary intervention
|
Wang Y.-H.;Kao H.-L.;Wang C.-C.;Lin S.-Y.;Fang-Ju Lin; Wang Y.-H.; Kao H.-L.; Wang C.-C.; Lin S.-Y.; FANG-JU LIN |
| 臺大學術典藏 |
2021-02-08T07:23:48Z |
Comparative Effectiveness and Safety of Dabigatran and Rivaroxaban in Atrial Fibrillation Patients
|
Lai C.-L.;Chen H.-M.;Liao M.-T.;Lin T.-T.;Kin-Wei Chan; Lai C.-L.; Chen H.-M.; Liao M.-T.; Lin T.-T.; KIN-WEI CHAN |
| 臺大學術典藏 |
2022-09-21T23:32:50Z |
Comparative Effectiveness and Safety of Different Combinations of Antithrombotic Regimens in Atrial Fibrillation Patients With Stent Insertions
|
Chueh, Han Hsin; Huang, Shih Tsung; Chang, Shang Hung; SHIN-YI LIN; FEI-YUAN HSIAO |
| 臺大學術典藏 |
2022-05-11T08:41:07Z |
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry
|
Lip, Gregory Y H; Kotalczyk, Agnieszka; Teutsch, Christine; Diener, Hans-Christoph; Dubner, Sergio J; Halperin, Jonathan L; Ma, Chang-Sheng; Rothman, Kenneth J; Marler, Sabrina; Gurusamy, Venkatesh Kumar; FU-TIEN CHIANG; Huisman, Menno V |
| 國立成功大學 |
2024-09 |
Comparative effectiveness and tolerability of calcitonin gene-related peptide (CGRP) monoclonal antibodies and onabotulinumtoxinA in chronic migraine: A multicenter, real-world study in Taiwan
|
Wang;Yen-Feng;Yang;Fu-Chi;Chen;Lu-An;Chang;Ting-Yu;Su;Hui-Chen;Yang;Chun-Pai;Tu;Yi-Hsien;Tzeng;Yi-Shiang;Chen;Shih-Pin;Fuh;Jong-Ling;Lai;Kuan-Lin;Ling;Yu-Hsiang;Chen;Wei-Ta;Wang;Shuu-Jiun |
| 國立成功大學 |
2024-04 |
Comparative Effectiveness of Adjuvant Therapy on Survival in Patients With Metastatic Colorectal Cancer
|
Wu;Chih-chien;Su;Chien-chou;Chen;Yu-hsun;Hsu;Chao-wen;Chang;Yu-ching;Su;Yi-chia |
| 臺大學術典藏 |
2018-09-10T18:07:27Z |
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: A nationwide high-risk cohort study
|
Ho, C.-M. and Lee, C.-H. and Lee, M.-C. and Zhang, J.-F. and Wang, J.-Y. and Hu, R.-H. and Lee, P.-H.; REY-HENG HU; CHENG-MAW HO |
| 臺大學術典藏 |
2020-02-11T03:53:49Z |
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: A nationwide high-risk cohort study
|
Cheng-Maw Ho;Lee C.-H.;Lee M.-C.;Zhang J.-F.;Wang J.-Y.;Hu R.-H.;Lee P.-H.; CHENG-MAW HO; Lee C.-H.; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; Hu R.-H.; Lee P.-H. |
| 臺大學術典藏 |
2020-02-24T01:33:43Z |
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: A nationwide high-risk cohort study
|
Ho C.-M.;Lee C.-H.;Lee M.-C.;Zhang J.-F.;Wang J.-Y.;Rey-Heng Hu;Lee P.-H.; Ho C.-M.; Lee C.-H.; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; REY-HENG HU; Lee P.-H. |
| 臺大學術典藏 |
2020-08-13T05:24:03Z |
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: A nationwide high-risk cohort study
|
Ho C.-M.; Lee C.-H.; Lee M.-C.; Zhang J.-F.; JANN-YUAN WANG; Hu R.-H.; Lee P.-H. |
| 臺大學術典藏 |
2018 |
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: A nationwide high-risk cohort study
|
Ho C.-M.;Lee C.-H.;Lee M.-C.;Zhang J.-F.;Wang J.-Y.;Hu R.-H.;Po-Huang Lee; Ho C.-M.; Lee C.-H.; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; Hu R.-H.; PO-HUANG LEE |
| 國家衛生研究院 |
2015-10 |
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in terms of major cardiovascular disease outcomes in elderly patients: A nationwide population-based cohort study
|
Chien, SC;Ou, SM;Shih, CJ;Chao, PW;Li, SY;Lee, YJ;Kuo, SC;Wang, SJ;Chen, TJ;Tarng, DC;Chu, H;Chen, YT |
| 國家衛生研究院 |
2016-05 |
Comparative effectiveness of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers in patients with type 2 diabetes and retinopathy
|
Shih, CJ;Chen, HT;Kuo, SC;Li, SY;Lai, PH;Chen, SC;Ou, SM;Chen, YT |
